EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cooperative Oligomeric Peptide Combinations Enhance the Predicted Therapeutic Profile of SET-M33

Ismael Castanon, Giovanni Cappello, Alessandro Rencinai iD, Laura Cresti iD, Eva Tollapi iD, Chiara Falciani iD, Alessandro Pini iD

Antibiotics · 09.06.2026 · 15 (6) · 591

DOI: 10.3390/antibiotics15060591 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antibiotics, online erschienen am 09.06.2026. Verfasst von Ismael Castanon und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Bioscience and Environmental Engineering, University of Stavanger, 4014 Stavanger, Norway. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union Horizon Europe MSCA DN-ID.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Antimicrobial peptides (AMPs) are promising candidates against multidrug-resistant bacteria, although their clinical translation is frequently limited by cytotoxicity. In this study, we investigated whether combinations of structurally related oligomeric analogs could cooperatively enhance bacterial membrane targeting while redistributing the associated cytotoxic burden.

Methods

Monomeric, dimeric, and tetrameric AMPs were evaluated through antimicrobial susceptibility testing, checkerboard interaction assays, RAW 264.7 macrophage cytotoxicity assays, and all-atom molecular dynamics simulations, including biased membrane insertion and umbrella sampling analyses. In addition, we introduced the Combinatorial Therapeutic Index (CTI) as an exploratory metric to estimate the predicted reduction in cytotoxic burden associated with peptide combinations.

Results

Cytotoxicity varied substantially among oligomeric forms, with larger and more hydrophobic peptides, particularly tetramers, exhibiting the highest cytotoxicity. Additive effects were observed in checkerboard assays involving linear, dimeric, and tetrameric forms, supporting the redistribution of the toxic burden and enabling the beneficial membrane-interaction properties of hydrophobic linear peptides to be leveraged at lower cytotoxic cost. Predicted therapeutic improvement ranged from approximately twofold for the SET-M33:L33 combination to nearly ninefold for the SET-M33:DIM-33:L8 triple combination. Molecular dynamics simulations revealed non-redundant membrane interaction behaviors, with smaller peptides exhibiting deeper membrane insertion and the dimeric form favoring interfacial membrane engagement.

Conclusions

These findings support a cooperative formulation strategy in which structurally related SET-M33 oligomers contribute complementary antibacterial functions while reducing the predicted cytotoxic burden. Further experimental validation using direct cytotoxicity assays of complete peptide mixtures will be necessary to confirm the therapeutic potential of these formulations.

Schlagwörter

Stichwörter der Autor:innen

antimicrobial peptidesdendrimeric peptidesmolecular dynamicspeptides poolrational design

Autor:innen und Institutionen

  • Department of Chemistry, Bioscience and Environmental Engineering, University of Stavanger, 4014 Stavanger, Norway.
  • Department of Medical Biotechnology, University of Siena, 53100 Siena, Italy.
  • SetLance SRL, Via Fiorentina 1, 53100 Siena, Italy.
  • Clinical Pathology Unit, Azienda Ospedaliera, Universitaria Senese, 53100 Siena, Italy.

ORCID-Profile: Alessandro Rencinai, Laura Cresti, Eva Tollapi, Chiara Falciani, Alessandro Pini

Förderung

  • European Union Horizon Europe MSCA DN-ID

Zitieren

APA

Castanon, I., Cappello, G., Rencinai, A., Cresti, L., Tollapi, E., Falciani, C., & Pini, A. (2026). Cooperative Oligomeric Peptide Combinations Enhance the Predicted Therapeutic Profile of SET-M33. Antibiotics, 15(6), 591. https://doi.org/10.3390/antibiotics15060591

Vancouver

Castanon I, Cappello G, Rencinai A, Cresti L, Tollapi E, Falciani C, et al. Cooperative Oligomeric Peptide Combinations Enhance the Predicted Therapeutic Profile of SET-M33. Antibiotics. 2026;15(6):591. doi:10.3390/antibiotics15060591

BibTeX
@article{Castanon2026,
  author = {Castanon, Ismael and Cappello, Giovanni and Rencinai, Alessandro and Cresti, Laura and Tollapi, Eva and Falciani, Chiara and Pini, Alessandro},
  title = {Cooperative Oligomeric Peptide Combinations Enhance the Predicted Therapeutic Profile of SET-M33},
  journal = {Antibiotics},
  year = {2026},
  volume = {15},
  number = {6},
  pages = {591},
  doi = {10.3390/antibiotics15060591}
}
Kostenlos starten →